Bioequivalency: Clinical Trials

8 trials for Bioequivalency, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

8 completed. 8 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 18Completed 8

Follow Bioequivalency: new trials by email Literature Review of Bioequivalency trials Research Report on Bioequivalency

Trials (filtered) newest first · largest first

All 8 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Bioequivalence Study of Iron Sucrose Injection in Healthy Participants
Iron Sucrose injection (Test product, manufactured by Sichuan Huiyu Pharmaceutical Co., Ltd) and Iron Sucrose injection (Reference product, Venofer), Iron Sucrose injection (Reference product, Venofer) and Iron Sucrose injection (Test product, manufactured by Sichuan Huiyu Pharmaceutical Co., Ltd) - Bioequivalency, Safety Issues
Phase 1CompletedSichuan Huiyu Pharmaceutical Co., Ltd482024-11-222025-03-24
Bioequivalence Study of Iron Sucrose Injection in Healthy Subjects
Iron Sucrose injection (Test product, manufactured by Sichuan Huiyu Pharmaceutical Co., Ltd) and Iron Sucrose injection (Reference product, Venofer), Iron Sucrose injection (Reference product, Venofer) and Iron Sucrose injection (Test product, manufactured by Sichuan Huiyu Pharmaceutical Co., Ltd) - Bioequivalency, Safety Issues
Phase 1CompletedSichuan Huiyu Pharmaceutical Co., Ltd482024-06-252024-10-08
A Single Dose BE Study of X-396 in Healthy Volunteers Under Fasted Conditions
Ensartinib Hydrochloride - Bioequivalency
Phase 1CompletedXcovery Holdings, Inc.322022-11-292024-02-20
Bioequivalence Study of Bicalutamide 50 mg Tablet and Casodex 50 mg Tablet in Healthy Subjects Under Fasting Conditions
Bicalutamide 50 mg Tablet vs Casodex® 50 mg Tablet - Bioequivalency
Phase 1CompletedKremers Urban Development Company602005-05-012009-12-24
Bioequivalence Study Between Two Oral Formulations of Naproxen 500 mg Tablets Under Fasting Conditions
Naproxen Tablets, 500 mg - Bioequivalency
Phase 1CompletedPerrigo Company342004-06-012012-03-16
Bioequivalence Study Between Two Oral Formulations of Naproxen 500 mg Tablets Under Fed Conditions
Naproxen Tablets, 500 mg - Bioequivalency
Phase 1CompletedPerrigo Company342004-06-012012-03-16
Bioequivalence Study Between Two Oral Formulations of Ibuprofen 800 mg Tablets Under Fasting Conditions
Ibuprofen Tablets, 800 mg - Bioequivalency
Phase 1CompletedPerrigo Company302004-01-012012-03-16
Bioequivalence Study Between Two Oral Formulations of Ibuprofen 800 mg Tablets Under Fed Conditions
Ibuprofen Tablets, 800 mg - Bioequivalency
Phase 1CompletedPerrigo Company302003-11-012012-03-16

Interventions

Ferric Oxide, Saccharated (2)  ·  Ibuprofen (2)  ·  Long-Term Synaptic Depression (2)  ·  Naproxen (2)  ·  Tablets (1)  ·  bicalutamide (1)  ·  ensartinib (1)

Sponsors

Perrigo Company (4)  ·  Sichuan Huiyu Pharmaceutical Co., Ltd (2)  ·  Kremers Urban Development Company (1)  ·  Xcovery Holdings, Inc. (1)

Countries

China (2)  ·  Canada (1)  ·  United States (1)

Top investigators

Chun Wan (1)  ·  Giovanni Selvaggi, MD (1)  ·  Richard Larouche, M.D. (1)